Prospect Financial Group
ABBV icon

Prospect Financial Group’s AbbVie ABBV Stock Holding History

Prospect Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$248K Sell
948
-191
-17% -$49K 0.21% 53
2026
Q2 		$287K Buy
1,139
+64
+6% +$13.8K 0.23% 57
2026
Q1 		$234K Sell
1,075
-63
-6% -$14K 0.22% 55
2025
Q4 		$260K Hold
1,138
– – 0.24% 49
2025
Q3 		$263K Buy
1,138
+2
+0.2% +$407 0.26% 49
2025
Q2 		$211K Buy
1,136
+56
+5% +$10.4K 0.22% 57
2025
Q1 		$226K Buy
+1,080
New +$210K 0.29% 53

Other funds holding ABBV

Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Bahl & Gaynor
Bahl & Gaynor Cincinnati, Ohio $21B AUM 23.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Prospect Financial Group's ABBV Position: Q3 2026 in Review

Prospect Financial Group reduced its AbbVie (ABBV) stake by 17% in Q3 2026, selling an estimated $49K and leaving 948 shares worth $248K. The position accounts for 0.21% of the portfolio, ranked #53.

Prospect Financial Group first reported a position in ABBV in Q1 2025 and has held it in 7 quarters since. The position peaked at $287K in Q2 2026. 2,502 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Prospect Financial Group held 948 shares of AbbVie worth $248K as of Q3 2026.
  • Prospect Financial Group sold 191 AbbVie shares in Q3 2026, an estimated $49K.
  • AbbVie made up 0.21% of Prospect Financial Group's portfolio in Q3 2026, its #53 holding.
  • Prospect Financial Group first reported a position in AbbVie in Q1 2025 and has held it in 7 quarters since.
  • Prospect Financial Group's AbbVie position peaked at $287K in Q2 2026.
  • 2,502 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Prospect Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.